Hong Zhong Cao
Directeur/Membre du Conseil chez Shandong Kexing Bioproducts Co., Ltd.
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Yan Qing Zhao | M | 42 |
Shandong Kexing Bioproducts Co., Ltd.
 Shandong Kexing Bioproducts Co., Ltd. Pharmaceuticals: MajorHealth Technology Shandong Kexing Bioproducts Co., Ltd. engages in the research and development, production, and sale of recombinant protein therapeutics and microbiota agents. Its products include recombinant human erythropoietin injections, recombinant human interferon a1b injections, recombinant human granulocyte stimulating factor injections, and clostridium butyricum double live bacteria powder and capsules. The company was founded on August 22, 1997 and is headquartered in Jinan, China. | 8 ans |
| Xue Qin Deng | M | 57 |
Shandong Kexing Bioproducts Co., Ltd.
Shandong Kexing Bioproducts Co., Ltd. Pharmaceuticals: MajorHealth Technology Shandong Kexing Bioproducts Co., Ltd. engages in the research and development, production, and sale of recombinant protein therapeutics and microbiota agents. Its products include recombinant human erythropoietin injections, recombinant human interferon a1b injections, recombinant human granulocyte stimulating factor injections, and clostridium butyricum double live bacteria powder and capsules. The company was founded on August 22, 1997 and is headquartered in Jinan, China. | 16 ans |
| Ning Cui | F | 47 |
Shandong Kexing Bioproducts Co., Ltd.
Shandong Kexing Bioproducts Co., Ltd. Pharmaceuticals: MajorHealth Technology Shandong Kexing Bioproducts Co., Ltd. engages in the research and development, production, and sale of recombinant protein therapeutics and microbiota agents. Its products include recombinant human erythropoietin injections, recombinant human interferon a1b injections, recombinant human granulocyte stimulating factor injections, and clostridium butyricum double live bacteria powder and capsules. The company was founded on August 22, 1997 and is headquartered in Jinan, China. | 14 ans |
| Xiao Qin Wang | F | 47 |
Shandong Kexing Bioproducts Co., Ltd.
Shandong Kexing Bioproducts Co., Ltd. Pharmaceuticals: MajorHealth Technology Shandong Kexing Bioproducts Co., Ltd. engages in the research and development, production, and sale of recombinant protein therapeutics and microbiota agents. Its products include recombinant human erythropoietin injections, recombinant human interferon a1b injections, recombinant human granulocyte stimulating factor injections, and clostridium butyricum double live bacteria powder and capsules. The company was founded on August 22, 1997 and is headquartered in Jinan, China. | 6 ans |
| An Tang | M | 67 |
Shandong Kexing Bioproducts Co., Ltd.
Shandong Kexing Bioproducts Co., Ltd. Pharmaceuticals: MajorHealth Technology Shandong Kexing Bioproducts Co., Ltd. engages in the research and development, production, and sale of recombinant protein therapeutics and microbiota agents. Its products include recombinant human erythropoietin injections, recombinant human interferon a1b injections, recombinant human granulocyte stimulating factor injections, and clostridium butyricum double live bacteria powder and capsules. The company was founded on August 22, 1997 and is headquartered in Jinan, China. | 5 ans |
| Hai Yan Jiang | F | 43 |
Shandong Kexing Bioproducts Co., Ltd.
Shandong Kexing Bioproducts Co., Ltd. Pharmaceuticals: MajorHealth Technology Shandong Kexing Bioproducts Co., Ltd. engages in the research and development, production, and sale of recombinant protein therapeutics and microbiota agents. Its products include recombinant human erythropoietin injections, recombinant human interferon a1b injections, recombinant human granulocyte stimulating factor injections, and clostridium butyricum double live bacteria powder and capsules. The company was founded on August 22, 1997 and is headquartered in Jinan, China. | 6 ans |
| Jian Hong Tao | M | 66 |
Shandong Kexing Bioproducts Co., Ltd.
Shandong Kexing Bioproducts Co., Ltd. Pharmaceuticals: MajorHealth Technology Shandong Kexing Bioproducts Co., Ltd. engages in the research and development, production, and sale of recombinant protein therapeutics and microbiota agents. Its products include recombinant human erythropoietin injections, recombinant human interferon a1b injections, recombinant human granulocyte stimulating factor injections, and clostridium butyricum double live bacteria powder and capsules. The company was founded on August 22, 1997 and is headquartered in Jinan, China. | 5 ans |
| Jiang Tao Bai | M | 47 |
Shandong Kexing Bioproducts Co., Ltd.
Shandong Kexing Bioproducts Co., Ltd. Pharmaceuticals: MajorHealth Technology Shandong Kexing Bioproducts Co., Ltd. engages in the research and development, production, and sale of recombinant protein therapeutics and microbiota agents. Its products include recombinant human erythropoietin injections, recombinant human interferon a1b injections, recombinant human granulocyte stimulating factor injections, and clostridium butyricum double live bacteria powder and capsules. The company was founded on August 22, 1997 and is headquartered in Jinan, China. | 8 ans |
| Hong Jie Ma | F | 53 |
Shandong Kexing Bioproducts Co., Ltd.
Shandong Kexing Bioproducts Co., Ltd. Pharmaceuticals: MajorHealth Technology Shandong Kexing Bioproducts Co., Ltd. engages in the research and development, production, and sale of recombinant protein therapeutics and microbiota agents. Its products include recombinant human erythropoietin injections, recombinant human interferon a1b injections, recombinant human granulocyte stimulating factor injections, and clostridium butyricum double live bacteria powder and capsules. The company was founded on August 22, 1997 and is headquartered in Jinan, China. | 5 ans |
| Hao Yun Liu | F | 39 |
Shandong Kexing Bioproducts Co., Ltd.
Shandong Kexing Bioproducts Co., Ltd. Pharmaceuticals: MajorHealth Technology Shandong Kexing Bioproducts Co., Ltd. engages in the research and development, production, and sale of recombinant protein therapeutics and microbiota agents. Its products include recombinant human erythropoietin injections, recombinant human interferon a1b injections, recombinant human granulocyte stimulating factor injections, and clostridium butyricum double live bacteria powder and capsules. The company was founded on August 22, 1997 and is headquartered in Jinan, China. | 1 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Yu Mei Zhu | F | 49 |
Shandong Kexing Bioproducts Co., Ltd.
Shandong Kexing Bioproducts Co., Ltd. Pharmaceuticals: MajorHealth Technology Shandong Kexing Bioproducts Co., Ltd. engages in the research and development, production, and sale of recombinant protein therapeutics and microbiota agents. Its products include recombinant human erythropoietin injections, recombinant human interferon a1b injections, recombinant human granulocyte stimulating factor injections, and clostridium butyricum double live bacteria powder and capsules. The company was founded on August 22, 1997 and is headquartered in Jinan, China. | 4 ans |
| Ya Xiao | F | 51 |
Shandong Kexing Bioproducts Co., Ltd.
Shandong Kexing Bioproducts Co., Ltd. Pharmaceuticals: MajorHealth Technology Shandong Kexing Bioproducts Co., Ltd. engages in the research and development, production, and sale of recombinant protein therapeutics and microbiota agents. Its products include recombinant human erythropoietin injections, recombinant human interferon a1b injections, recombinant human granulocyte stimulating factor injections, and clostridium butyricum double live bacteria powder and capsules. The company was founded on August 22, 1997 and is headquartered in Jinan, China. | 3 ans |
| Jia Wen | F | 45 |
Shandong Kexing Bioproducts Co., Ltd.
Shandong Kexing Bioproducts Co., Ltd. Pharmaceuticals: MajorHealth Technology Shandong Kexing Bioproducts Co., Ltd. engages in the research and development, production, and sale of recombinant protein therapeutics and microbiota agents. Its products include recombinant human erythropoietin injections, recombinant human interferon a1b injections, recombinant human granulocyte stimulating factor injections, and clostridium butyricum double live bacteria powder and capsules. The company was founded on August 22, 1997 and is headquartered in Jinan, China. | 4 ans |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Chine | 13 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Hong Zhong Cao
- Réseau Personnel
